MiniTC® for Microfat
Broad Regenerative Injection Therapy (Pain, Orthopedics, Sports Med, Aesthetics, etc.)
CommercialActive
Key Facts
Indication
Broad Regenerative Injection Therapy (Pain, Orthopedics, Sports Med, Aesthetics, etc.)
Phase
Commercial
Status
Active
Company
About Jointech Labs
Jointech Labs is an emerging leader in the point-of-care regenerative medicine sector, founded in 2019 and headquartered in San Francisco. Its core technology is the MiniTC® Adipose Processing System, an FDA-cleared, disposable device that enables clinicians to process autologous fat into high-quality microfat for injection in various clinical settings, including orthopedics, sports medicine, and aesthetics. The company is privately held, commercializing its first device while expanding its geographic footprint and clinical applications. Its mission is to advance regenerative therapies into a standard-of-care option for doctors and patients worldwide.
View full company profile